Decision Diagnostics (Decision Diagnostics) Pre-Tax Income : $-8.29 Mil (TTM As of Sep. 2021)

View and export this data going back to . Start your Free Trial

What is Decision Diagnostics Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Decision Diagnostics's pretax income for the three months ended in Sep. 2021 was $-0.56 Mil. Its pretax income for the trailing twelve months (TTM) ended in Sep. 2021 was $-8.29 Mil. Decision Diagnostics's pretax margin was -106.94%.

Decision Diagnostics Pre-Tax Income Historical Data

The historical data trend for Decision Diagnostics's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Decision Diagnostics Pre-Tax Income Chart

Decision Diagnostics Annual Data

Trend

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec17

Dec18

Dec19

Dec20

Pre-Tax Income

Get a 7-Day Free Trial

-3.08

-2.99

-2.24

-3.13

-29.67

Decision Diagnostics Quarterly Data
	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec17	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21
Pre-Tax Income	Get a 7-Day Free Trial															-4.73	-6.92	-0.52	-0.30	-0.56

Competitive Comparison of Decision Diagnostics's Pre-Tax Income

For the Pharmaceutical Retailers subindustry, Decision Diagnostics's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Decision Diagnostics's Pre-Tax Income Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Decision Diagnostics's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Decision Diagnostics's Pre-Tax Income falls into.

Decision Diagnostics Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Decision Diagnostics's Pretax Income for the fiscal year that ended in Dec. 2020 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-2.101	+	0	+	-27.263	+	0	+	-0.305
	=	-29.67

Decision Diagnostics's Pretax Income for the quarter that ended in Sep. 2021 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-0.491	+	0	+	-0.064	+	0	+	-1.1102230246252E-16
	=	-0.56

Pre-Tax Income for the trailing twelve months (TTM) ended in Sep. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-8.29 Mil.

Decision Diagnostics (OTCPK:DECN) Pre-Tax Income Explanation

Decision Diagnostics's Pretax Margin for the quarter that ended in Sep. 2021 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-0.555	/	0.519
	=	-106.94%

Decision Diagnostics Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Decision Diagnostics's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Decision Diagnostics (Decision Diagnostics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Decision Diagnostics Corp (OTCPK:DECN) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

2660 Townsgate Road, Suite 300, Westlake Village, CA, USA, 91361

Website

http://www.decisiondiagnostics.co

Decision Diagnostics Corp is a provider of prescription drugs, home testing products for the chronically ill, direct to patient diabetes programs, and a developer of revolutionary, cell phone centric, e-health products and technology. The company also provides blood glucose home testing test strips and exciting new concepts for blood testing monitors.

Executives

Keith Berman	director, officer: Secretary	2660 TOWNSGATE RD #300, WESTLAKE VILLAGE CA 91361
Robert Jagunich	director	765 CHRISTINE DR PALO ALTO CA 94303
Robert Lawrence Cox	director, officer: President